Hemophagocytic lymphohistiocytosis‐like toxicity (carHLH) after CD19‐specific CAR T‐cell therapyMelissa Hines, Aimee C. Talleur, Camille Keenan et al.|British Journal of Haematology|2021Cited by 122
Preferential expansion of CD8+ CD19-CAR T cells postinfusion and the role of disease burden on outcome in pediatric B-ALLAimee C. Talleur, Stephen Gottschalk, Amr Qudeimat et al.|Blood Advances|2022Cited by 62
Pathobiological signatures of dysbiotic lung injury in pediatric patients undergoing stem cell transplantationMatt S. Zinter, Joseph L. DeRisi, Paul Martin et al.|Nature Medicine|2024Cited by 19
Integrating pulmonary and systemic transcriptomes to characterize lung injury after pediatric hematopoietic stem cell transplantEmma Pearce, Matt S. Zinter, Erica Evans et al.|JCI Insight|2025Cited by 2
Pulmonary microbiome and transcriptome signatures reveal distinct pathobiologic states associated with mortality in two cohorts of pediatric stem cell transplant patientsMatt S. Zinter, Joseph L. DeRisi, Christopher C. Dvorak et al.|medRxiv|2023Cited by 1